Patent · US Active

Modified lipidated relaxin B chain peptides and their therapeutic use

US11725036B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

Sanofi · FR

Inventors

Olivier Duclos · Paris, FR
Stéphane Illiano · Paris, FR
Sergio Mallart · Paris, FR
Claire Minoletti-Hochepied · Paris, FR
Elisabetta Bianchi · Pomezia, IT
Raffaele Ingenito · Pomezia, IT
Paola Magotti · Frederiksværk, DK
Alessia Santoprete · Pomezia, IT

Key dates

Filing date	Oct 30, 2020
Grant date	Aug 15, 2023
Priority date	—
Expiry date	Oct 30, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A biologically active single chain Relaxin peptide having the formula Nter-Ac-L-E-G-R-E-K-V-R-A-X19-I-X21-X22-E-G-X25-S-T-F-S-X30-R-A-X33-NH2-Cter, or a salt of solvate thereof, is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.